Skip to Main Content

Medtronic plc

MDT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

$MDT is featured in our Dan Meuser strategy.

See All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MDT by members of U.S. Congress

Politician Type Traded
Emily Randall House / D Sale $1,001 - $15,000 Jan. 06, 2025
John James House / R Sale $1,001 - $15,000 Sep. 04, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Aug. 26, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Jul. 09, 2024
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul. 02, 2024
John James House / R Purchase $1,001 - $15,000 Jun. 18, 2024
John James House / R Sale $1,001 - $15,000 Jun. 03, 2024
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Feb. 09, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Kathy E. Manning House / D Purchase $15,001 - $50,000 Jan. 23, 2024
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec. 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec. 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec. 28, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec. 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec. 12, 2023
Kathy E. Manning House / D Sale $15,001 - $50,000 Dec. 12, 2023
Debbie Dingell House / D Purchase $15,001 - $50,000 Dec. 05, 2023
John James House / R Purchase $1,001 - $15,000 Nov. 10, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Pete Ricketts Senate / R Sale (Full) $50,001 - $100,000 Sep. 21, 2023
Michael Guest House / R Purchase $1,001 - $15,000 Aug. 07, 2023
Pete Sessions House / R Sale $15,001 - $50,000 Jun. 15, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Apr. 28, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Apr. 28, 2023
Tina Smith Senate / D Sale (Full) $100,001 - $250,000 Apr. 05, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar. 06, 2023
C. Scott Franklin House / R Sale $50,001 - $100,000 Feb. 15, 2023
Kevin Hern House / R Sale $1,001 - $15,000 Jan. 31, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Jan. 31, 2023
Bob Gibbs House / R Sale $15,001 - $50,000 Dec. 21, 2022
Dan Sullivan Senate / R Sale (Full) $1,001 - $15,000 Nov. 30, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Oct. 12, 2022
C. Scott Franklin House / R Purchase $15,001 - $50,000 Sep. 13, 2022
C. Scott Franklin House / R Purchase $1,001 - $15,000 Sep. 13, 2022
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Jul. 29, 2022
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Jul. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
William R. Keating House / D Sale $1,001 - $15,000 Mar. 29, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Mar. 16, 2022
Earl Blumenauer House / D Sale $1,001 - $15,000 Mar. 14, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 22, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 18, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 11, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 09, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 03, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 02, 2022
MDT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MDT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by MDT's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

MDT Revenue by Segment or Geography

By Segment
By Geography
MDT Income Statement
MDT Balance Sheet
MDT Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Thermal transfer system and method Feb. 04, 2025
  • Patent Title: Minimally invasive leadless neurostimulation device Feb. 04, 2025
  • Patent Title: Atrial tracking in an intracardiac ventricular pacemaker Feb. 04, 2025
  • Patent Title: Tools and assemblies thereof for implantable medical devices Feb. 04, 2025
  • Patent Title: Calibration for ecap sensing Jan. 28, 2025
  • Patent Title: Fixation for implantable medical devices Jan. 28, 2025
  • Patent Title: Cardiac pulsed field ablation Jan. 28, 2025
  • Patent Title: Wireless recharging devices and methods based on thermal boundary conditions Jan. 21, 2025
  • Patent Title: Robust adaptive brain stimulation Jan. 21, 2025
  • Patent Title: Synchronizing external electrical activity Jan. 21, 2025
  • Patent Title: Implantable lead migration monitoring using ecap Jan. 21, 2025
  • Patent Title: Stimulation therapy for treating obstructive sleep apnea (osa) based on compound muscle action potential (cmap) Jan. 21, 2025
  • Patent Title: Mechanical feedthroughs for implantable medical device Jan. 21, 2025
  • Patent Title: Ventricular assist device and cardiac electrical stimulation system for therapy control Jan. 21, 2025
  • Patent Title: Electrospun medical devices and methods of making electrospun medical devices Jan. 21, 2025
  • Patent Title: Paravalvular leak resistant prosthetic heart valve system Jan. 21, 2025
  • Patent Title: System and method for detecting medical device delivery tool position Jan. 21, 2025
  • Patent Title: Detection and localization of myocardial infarction using vectorcardiography Jan. 21, 2025
  • Patent Title: Cardiac pulsed field ablation Jan. 21, 2025
  • Patent Title: Implantable medical device using internal sensors to determine when to switch operational modes Jan. 14, 2025
  • Patent Title: Mode switching in a ventricular pacemaker to promote atrioventricular conduction Jan. 14, 2025
  • Patent Title: Managing therapy delivery based on physiological markers Jan. 14, 2025
  • Patent Title: Implantable medical lead Jan. 14, 2025
  • Patent Title: Interventional medical device and method of use Jan. 14, 2025
  • Patent Title: Shuttle apparatus and associated systems and methods Jan. 14, 2025
  • Patent Title: Extended reality (xr) applications for cardiac arrhythmia procedures Jan. 14, 2025
  • Patent Title: Implantable medical sensor and fixation system Jan. 14, 2025
  • Patent Title: Implantable medical lead with shield Jan. 07, 2025
  • Patent Title: Multi-threshold sensing of cardiac electrical signals in an implantable medical device Jan. 07, 2025
  • Patent Title: Atrial tracking in an intracardiac ventricular pacemaker Jan. 07, 2025
  • Patent Title: Hysteresis compensation for detection of ecaps Jan. 07, 2025
  • Patent Title: Method and device for percutaneous valve annuloplasty Jan. 07, 2025
  • Patent Title: Optical based glucose sensor Jan. 07, 2025
  • Patent Title: Implantable medical device Dec. 31, 2024
  • Patent Title: Tissue conduction communication using ramped drive signal Dec. 31, 2024
  • Patent Title: Fixation component for multi-electrode implantable medical device Dec. 31, 2024
  • Patent Title: Patient state determination based on one or more spectral characteristics of a bioelectrical brain signal Dec. 31, 2024
  • Patent Title: Detection and mitigation of inaccurate sensing by an implanted sensor of a medical system Dec. 31, 2024
  • Patent Title: Extravascular implant tools utilizing a bore-in mechanism and implant techniques using such tools Dec. 31, 2024
  • Patent Title: Capture in ventricle-from-atrium cardiac therapy Dec. 24, 2024
  • Patent Title: Medical device and method for generating modulated high frequency electrical stimulation pulses Dec. 24, 2024
  • Patent Title: Compact implantable medical device and delivery device Dec. 24, 2024
  • Patent Title: Skirt-reinforcement members for prosthetic valve devices Dec. 24, 2024
  • Patent Title: Marker monitoring via a medical device Dec. 24, 2024
  • Patent Title: Safety default return path for electric field therapy Dec. 24, 2024
  • Patent Title: Recapturable left atrial appendage clipping device and methods for recapturing a left atrial appendage clip Dec. 24, 2024
  • Patent Title: Electrolyte additive in primary batteries for medical devices Dec. 17, 2024
  • Patent Title: Composite separator and electrolyte for electrochemical cells Dec. 17, 2024
  • Patent Title: Stimulation induced neural response for parameter selection Dec. 17, 2024
  • Patent Title: Posture-based control of electrical stimulation therapy Dec. 17, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
MDT News

Recent insights relating to MDT

WallStreetBets

Number of mentions of MDT in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for MDT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDT

MDT Top Shareholders
Shareholder
Shares Held
MDT Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top